Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

類似資料

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  著者:: Martini A, 等
  出版事項: (2011-09-01)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  著者:: Bibalo, C, 等
  出版事項: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  著者:: Caorsi, Roberta, 等
  出版事項: (2013)
• An experience of use of canakinumab IL-1 inhibitor in children with cryopyrin-associated periodic syndromes (CAPS)
  著者:: Salugina, Svetlana O, 等
  出版事項: (2014)
• Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
  著者:: Bader-Meunier, B, 等
  出版事項: (2011)